WebThrough the acquisition, Curi will gain access to Dana's AI/ML-based platforms including PhenoLearn™, a deep learning platform for modeling cell and tissue phenotypes; Pulse™, an automated platform for contractility analysis of beating cardiomyocytes; and PhenoTox™, a patented deep learning platform for predictive safety pharmacology. WebJul 24, 2024 · Through the acquisition, Curi will gain Dana's portfolio of AI and machine learning (ML) platforms, which include PhenoLearn for cell and tissue phenotype modeling, Pulse for contractility analysis of beating cardiomyocytes, and PhenoTox for predictive safety pharmacology.

Mahnaz Maddah - Director, Machine Learning - LinkedIn

WebA local testbench for ML configuration iteration. Contribute to CuriBio/phenolearn-local development by creating an account on GitHub. WebJul 23, 2024 · Through the acquisition, Curi will gain access to Dana’s AI/ML-based platforms including PhenoLearn™, a deep learning platform for modeling cell and tissue … hrsa part b

Curi Bio Acquires Dana Solutions. - Free Online Library

WebApr 4, 2024 · Since then, a variety of explanations focused on latitude-associated gradients in biotic and abiotic factors have been proposed to account for the assumed increases in tropical species ... WebView PhenoLearn (www.phenolearn.com) location , revenue, industry and description. Find related and similar companies as well as employees by title and much more. WebNov 4, 2024 · FCR001 is a cryopreserved allogeneic stem cell therapy derived from mobilized peripheral blood of the kidney donor that is delivered as a single dose in kidney transplant recipients who received a nonmyeloablative conditioning regimen. FCR001 contains the donor’s CD34 + cells, facilitating cells and αβ T-cells. figyelemhiány zavar